The Bone-Muscle Unit: An Integrative Treatment Guide

Most physicians screen for bone loss and muscle loss as two separate problems. They share a cellular origin and signal to each other constantly, and when they decline together, the combined condition carries far worse outcomes than either alone.

Stacey J. Robinson, MD (ABFM, ABoIM, AFMCP), founder of Robinson MD, treats them as a single system. Her framework moves from physiology through screening, nutrition, and exercise to a layered set of treatments. The goal is to build reserves before patients lose them.

Treating Bone and Muscle as One System

Bone and muscle both develop from mesenchymal stem cells and communicate continuously through paracrine signaling. This kind of systems thinking sits at the core of functional and integrative medicine, which traces symptoms back to shared upstream causes. Loading muscle releases signals that stimulate bone formation, and unloading muscle releases signals that suppress it.

The decline of bone and muscle is one connected process, not two parallel ones. Excess insulin and chronic inflammation push stem-cell differentiation toward fat.

Fat then infiltrates muscle, driving further local inflammation. The cycle compounds: more fat means worse bone and worse muscle.

The combined condition, osteosarcopenia, affects roughly 28% of women and 15.7% of men. The source guide cites a tenfold increase in mortality risk compared to patients without it.

Screening and Biomarkers Earlier Than Standard

Dr. Robinson recommends a baseline DEXA scan at age 40 for both men and women rather than waiting for the standard screening age, part of a broader move toward earlier screening and assessment tools. A T-score of -1.0 to -2.5 indicates osteopenia, and below -2.5 indicates osteoporosis. Tracking skeletal muscle mass with DEXA or BIA, plus a simple grip-strength check, captures the sarcopenia side.

Catching decline early depends on measuring both bone and muscle before symptoms appear. Resorption markers like urine NTX and serum CTX, available at commercial labs, can be very helpful to monitor bone loss to determine if interventions are effective. Useful targets include hs-CRP under 0.9 mg/L, fasting insulin under 10 uIU/mL, and optimized estradiol, testosterone, and IGF-1 levels, since insulin resistance and inflammation are the upstream drivers to correct first.

Patients with osteoporosis are 17 times more likely to have celiac disease, and 56% of those with celiac have osteopenia and 30% have osteoporosis. Dr. Robinson advises ruling out celiac in every osteoporosis patient.

Nutrition and Protein for the Bone-Muscle Unit

A Mediterranean-style whole-food pattern shows the strongest association with bone health across the evidence base. The emphasis falls on vegetables, fruit, whole grains, fish, nuts, legumes, and low-fat dairy, with soft drinks, fried foods, processed meats, and refined grains pushed to the margins.

Protein intake drives the muscle half of the equation as directly as resistance training does. Dr. Robinson sets a minimum of 1.4 g/kg/day, with at least 25 grams per meal to stimulate muscle protein synthesis. Protein sources highest in leucine most effectively stimulate muscle protein synthesis. These include whey protein (which surpasses casein in leucine content), beef, fish, and eggs.

Vegetarian and vegan patients are at higher risk and benefit more from leucine-rich choices and, in some cases, supplementation.

Resistance Training as the Most Osteogenic Intervention

Resistance training is the most osteogenic intervention available, supported by more than 59 controlled trials, seven meta-analyses, and eight systematic reviews. Walking alone has a limited effect on bone mineral density and shouldn’t carry the load as a primary intervention.

Bone and muscle both respond to mechanical stress, which makes loading the body the central prescription. Dr. Robinson recommends pairing load-based activities, such as jumping and dynamic HIIT, with progressive resistance training at least three times a week. Both types matter for the bone-muscle unit.

The cost of skipping it is steady. Without resistance training after age 30, patients lose 3% to 8% of skeletal muscle mass and 1% to 3% of bone mineral density per decade. Preserving that capacity early is the same principle that drives a sound approach to healthspan medicine: protect the basics before chasing more exotic interventions.

The Integrative Layer: Supplements, Hormones, and Peptides

Several nutraceuticals carry reasonable support. Five grams of hydrolyzed collagen daily has improved bone mineral density in postmenopausal women, and a randomized trial of Urolithin A showed gains in muscle strength and endurance alongside a roughly 50% drop in CRP. Dr. Robinson also uses vitamin D3 with K2 and calcium, plus magnesium, though her vitamin D target of 75 to 90 ng/mL sits above mainstream guideline ranges of about 30 to 50 ng/mL.

The integrative layer works best built on a foundation of nutrition, exercise, and gut health, with the evidence behind each agent kept in clear view. Hormone therapy, using transdermal estradiol and testosterone, is both antiresorptive and anabolic, and the updated thinking on hormone therapy applies directly to bone outcomes. Standard pharmaceutical classes still apply, including bisphosphonates, denosumab, SERMs, PTH analogues, and romosozumab.

Other considerations, such as peptides, are experimental and off-label. BPC-157, KPV, and larazotide are sometimes used to repair the gut barrier in treatment-resistant cases, where intestinal malabsorption drives osteoporosis in patients who lack typical risk factors. Sermorelin, ipamorelin, and tesamorelin could be considered when IGF-1 is low.

These are off-label and not FDA-approved. The guide notes that the GHR peptide evidence is currently limited to animal models, with larazotide still in late-phase human trials.

Building Reserves Before They’re Gone

The most powerful intervention is prevention. Integrative and pharmaceutical approaches work together rather than competing, layered on optimized nutrition, movement, and metabolic health.

For entrepreneurial physicians refining how they screen and treat aging patients, joining Private Physicians Alliance provides access to a curated network of peers who compare evidence, debate protocols, and discuss complex cases in confidential forums. Learn more about PPA membership today.

Written by Dr. Stacey Robinson, PPA Member and Founder of Robinson MD in St. Petersburg, Florida.